You don't even make sense. What has psychedelics got to do with Cochlear? The company has multiple arms to its clinical program which is why I love the fact that they've continued to diversify risk.
It's certainly not being valued as if it was to capture the global OSA market because it would be worth billions - today's announcement I think justifies its valuation all day every day for the reasons I posted earlier so what pearls of wisdom do you have to share with us apart from your one line cautionary comment?
Ted
IHL Price at posting:
27.0¢ Sentiment: Buy Disclosure: Held